Skip to main content
. 2022 Aug 22;7(5):100558. doi: 10.1016/j.esmoop.2022.100558

Figure 1.

Figure 1

Progression-free survival comparing PARPi versus placebo: Combined whole population individual patient data from three RCTs (excluding trial by Moore et al.17). (A) Progression-free survival curve. (B) Forest plot. CI, confidence interval; HR, hazard ratio; PARPi, poly(ADP-ribose) polymerase inhibitor; PFS, progression-free survival; RCT, randomized controlled trial.